CD&R and McKesson to Acquire Option Care Health for $5.8B
Clayton, Dubilier & Rice and McKesson agree to acquire Option Care Health for $32.05 per share in cash, valuing the infusion provider at $5.8 billion.
mckesson
McKesson to Buy Precision Medicine Group for $2.25B
McKesson unveiled a $2.25B deal for Precision Medicine Group, doubling down on its fastest-growing segment: Oncology & Multispecialty.